Table of Contents Chapter 1 Overview of Foot Ulcer Therapeutic 1.1 Definition of Foot Ulcer Therapeutic in This Report 1.2 Commercial Types of Foot Ulcer Therapeutic 1.2.1 Advance Wound Dressings 1.2.2 Skin Substitutes 1.2.3 Negative Pressure Wound Therapy Devices 1.3 Downstream Application of Foot Ulcer Therapeutic 1.3.1 Hospitals 1.3.2 Specialty Clinics 1.3.3 Long-Term Care Centers 1.3.4 Ambulatory Surgical Centers 1.4 Development History of Foot Ulcer Therapeutic 1.5 Market Status and Trend of Foot Ulcer Therapeutic 2013-2023 1.5.1 North America Foot Ulcer Therapeutic Market Status and Trend 2013-2023 1.5.2 Regional Foot Ulcer Therapeutic Market Status and Trend 2013-2023 Chapter 2 North America Market Status and Forecast by Regions 2.1 Market Status of Foot Ulcer Therapeutic in North America 2013-2017 2.2 Consumption Market of Foot Ulcer Therapeutic in North America by Regions 2.2.1 Consumption Volume of Foot Ulcer Therapeutic in North America by Regions 2.2.2 Revenue of Foot Ulcer Therapeutic in North America by Regions 2.3 Market Analysis of Foot Ulcer Therapeutic in North America by Regions 2.3.1 Market Analysis of Foot Ulcer Therapeutic in United States 2013-2017 2.3.2 Market Analysis of Foot Ulcer Therapeutic in Canada 2013-2017 2.3.3 Market Analysis of Foot Ulcer Therapeutic in Mexico 2013-2017 2.4 Market Development Forecast of Foot Ulcer Therapeutic in North America 2018-2023 2.4.1 Market Development Forecast of Foot Ulcer Therapeutic in North America 2018-2023 2.4.2 Market Development Forecast of Foot Ulcer Therapeutic by Regions 2018-2023 Chapter 3 North America Market Status and Forecast by Types 3.1 Whole North America Market Status by Types 3.1.1 Consumption Volume of Foot Ulcer Therapeutic in North America by Types 3.1.2 Revenue of Foot Ulcer Therapeutic in North America by Types 3.2 North America Market Status by Types in Major Countries 3.2.1 Market Status by Types in United States 3.2.2 Market Status by Types in Canada 3.2.3 Market Status by Types in Mexico 3.3 Market Forecast of Foot Ulcer Therapeutic in North America by Types Chapter 4 North America Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Foot Ulcer Therapeutic in North America by Downstream Industry 4.2 Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in Major Countries 4.2.1 Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in United States 4.2.2 Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in Canada 4.2.3 Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in Mexico 4.3 Market Forecast of Foot Ulcer Therapeutic in North America by Downstream Industry Chapter 5 Market Driving Factor Analysis of Foot Ulcer Therapeutic 5.1 North America Economy Situation and Trend Overview 5.2 Foot Ulcer Therapeutic Downstream Industry Situation and Trend Overview Chapter 6 Foot Ulcer Therapeutic Market Competition Status by Major Players in North America 6.1 Sales Volume of Foot Ulcer Therapeutic in North America by Major Players 6.2 Revenue of Foot Ulcer Therapeutic in North America by Major Players 6.3 Basic Information of Foot Ulcer Therapeutic by Major Players 6.3.1 Headquarters Location and Established Time of Foot Ulcer Therapeutic Major Players 6.3.2 Employees and Revenue Level of Foot Ulcer Therapeutic Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Foot Ulcer Therapeutic Major Manufacturers Introduction and Market Data 7.1 B. Braun Melsungen AG 7.1.1 Company profile 7.1.2 Representative Foot Ulcer Therapeutic Product 7.1.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG 7.2 Smith & Nephew, Inc. 7.2.1 Company profile 7.2.2 Representative Foot Ulcer Therapeutic Product 7.2.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Smith & Nephew, Inc. 7.3 Organogenesis, Inc. 7.3.1 Company profile 7.3.2 Representative Foot Ulcer Therapeutic Product 7.3.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Organogenesis, Inc. 7.4 Derma Sciences Inc. 7.4.1 Company profile 7.4.2 Representative Foot Ulcer Therapeutic Product 7.4.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Derma Sciences Inc. 7.5 Sigvaris Inc. 7.5.1 Company profile 7.5.2 Representative Foot Ulcer Therapeutic Product 7.5.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Sigvaris Inc. 7.6 3M 7.6.1 Company profile 7.6.2 Representative Foot Ulcer Therapeutic Product 7.6.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of 3M 7.7 Acelity L.P. Inc. 7.7.1 Company profile 7.7.2 Representative Foot Ulcer Therapeutic Product 7.7.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Acelity L.P. Inc. 7.8 Innocoll Holdings plc. 7.8.1 Company profile 7.8.2 Representative Foot Ulcer Therapeutic Product 7.8.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Innocoll Holdings plc. 7.9 SIGVARIS, Inc. 7.9.1 Company profile 7.9.2 Representative Foot Ulcer Therapeutic Product 7.9.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of SIGVARIS, Inc. Chapter 8 Upstream and Downstream Market Analysis of Foot Ulcer Therapeutic 8.1 Industry Chain of Foot Ulcer Therapeutic 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Foot Ulcer Therapeutic 9.1 Cost Structure Analysis of Foot Ulcer Therapeutic 9.2 Raw Materials Cost Analysis of Foot Ulcer Therapeutic 9.3 Labor Cost Analysis of Foot Ulcer Therapeutic 9.4 Manufacturing Expenses Analysis of Foot Ulcer Therapeutic Chapter 10 Marketing Status Analysis of Foot Ulcer Therapeutic 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Advance Wound Dressings Table Advantage and Disadvantage of Skin Substitutes Table Advantage and Disadvantage of Negative Pressure Wound Therapy Devices Table Consumption Volume of Foot Ulcer Therapeutic in North America by Regions 2013-2017 Table Revenue of Foot Ulcer Therapeutic in North America by Regions 2013-2017 Table Consumption Volume of Foot Ulcer Therapeutic in North America by Regions 2018-2023 Table Revenue of Foot Ulcer Therapeutic in North America by Regions 2018-2023 Table Consumption Volume of Foot Ulcer Therapeutic in North America by Types 2013-2017 Table Revenue of Foot Ulcer Therapeutic in North America by Types 2013-2017 Table Consumption Volume of Foot Ulcer Therapeutic by Types in United States 2013-2017 Table Consumption Volume of Foot Ulcer Therapeutic by Types in Canada 2013-2017 Table Consumption Volume of Foot Ulcer Therapeutic by Types in Mexico 2013-2017 Table Consumption Volume Forecast of Foot Ulcer Therapeutic in North America by Types 2018-2023 Table Revenue Forecast of Foot Ulcer Therapeutic in North America by Types 2018-2023 Table Demand Volume of Foot Ulcer Therapeutic in North America by Downstream Industry 2013-2017 Table Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in United States 2013-2017 Table Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in Canada 2013-2017 Table Demand Volume of Foot Ulcer Therapeutic by Downstream Industry in Mexico 2013-2017 Table Demand Volume Forecast of Foot Ulcer Therapeutic in North America by Downstream Industry 2018-2023 Table Sales Volume of Foot Ulcer Therapeutic in North America by Major Players 2013-2017 Table Revenue of Foot Ulcer Therapeutic in North America by Major Players 2013-2017 Table Headquarters Location and Established Time of Foot Ulcer Therapeutic Major Players Table Employees and Revenue Level of Foot Ulcer Therapeutic Major Players Table Representative Foot Ulcer Therapeutic Product One of B. Braun Melsungen AG Table Representative Foot Ulcer Therapeutic Product Two of B. Braun Melsungen AG Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Smith & Nephew, Inc. Table Representative Foot Ulcer Therapeutic Product Two of Smith & Nephew, Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Smith & Nephew, Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Organogenesis, Inc. Table Representative Foot Ulcer Therapeutic Product Two of Organogenesis, Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Organogenesis, Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Derma Sciences Inc. Table Representative Foot Ulcer Therapeutic Product Two of Derma Sciences Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Derma Sciences Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Sigvaris Inc. Table Representative Foot Ulcer Therapeutic Product Two of Sigvaris Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Sigvaris Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of 3M Table Representative Foot Ulcer Therapeutic Product Two of 3M Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of 3M 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Acelity L.P. Inc. Table Representative Foot Ulcer Therapeutic Product Two of Acelity L.P. Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Acelity L.P. Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Innocoll Holdings plc. Table Representative Foot Ulcer Therapeutic Product Two of Innocoll Holdings plc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Innocoll Holdings plc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of SIGVARIS, Inc. Table Representative Foot Ulcer Therapeutic Product Two of SIGVARIS, Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of SIGVARIS, Inc. 2013-2017